ORAMED PHARMACEUTICALS INC. - 10-Q Filing

Oramed Pharmaceuticals reports significant revaluation losses on Lifeward instruments and debt conversions for the nine months ended September 30, 2026.

SEC EDGAR · November 12, 2026, 22:23 UTC

Tickers: $ORMP

Read the full article at SEC EDGAR

Part of the story ELITE PHARMACEUTICALS INC /NV/ - 10-Q Filing (3 articles)

More Regulatory news

BT Brands, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:32 UTC
MICROVISION, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 22:31 UTC
Fermi Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:29 UTC
Freenome, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:29 UTC
MEXCO ENERGY CORP - 8-K Filing SEC EDGAR · November 12, 2026, 22:28 UTC
SHF Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 22:28 UTC
SILVER BOW MINING CORP. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:27 UTC
HOST HOTELS & RESORTS, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 22:27 UTC
LGL GROUP INC - 10-Q Filing SEC EDGAR · November 12, 2026, 22:27 UTC
Bright Mountain Media, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 22:27 UTC